GM1 Gangliosidoses: Clinical Trials

3 trials for GM1 Gangliosidoses, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 recruiting, 1 terminated. 1 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 11Not yet recruiting 1
Phase 41Terminated 1

Follow GM1 Gangliosidoses: new trials by email Literature Review of GM1 Gangliosidoses trials Research Report on GM1 Gangliosidoses

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prenatal Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis Clinical Trial
Gene Transfer with an AAV9 Vector Expressing Human ß-galactosidase - GM1 Gangliosidoses, GM1 Gangliosidosis, Type I
Phase 1Not yet recruitingTippi Mackenzie52027-01-012026-08-31
Synergistic Enteral Regimen for Treatment of the Gangliosidoses
miglustat, Ketogenic Diet - GM1 Gangliosidoses, GM2 Gangliosidoses
Phase 4TerminatedUniversity of Minnesota162015-12-222021-04-14
Longitudinal Study of Neurodegenerative Disorders
Palliative Care, Hematopoetic Stem Cell Transplantation - MLD, Krabbe Disease
RecruitingUniversity of Pittsburgh15002012-01-112026-02-09

Narrower conditions

Gangliosidosis, GM1 (2)  ·  Sandhoff Disease (2)  ·  Tay-Sachs Disease (2)  ·  Gangliosidoses (1)  ·  Gangliosidoses, GM2 (1)  ·  Gaucher Disease (1)  ·  Hypermethioninemia (1)  ·  Language (1)  ·  Leukodystrophy, Globoid Cell (1)  ·  Leukoencephalopathies (1)  ·  Lysosomal Storage Diseases (1)  ·  Mucopolysaccharidosis III (1)  ·  Mucopolysaccharidosis IV (1)  ·  Multiple Sulfatase Deficiency Disease (1)  ·  Neuronal Ceroid-Lipofuscinoses (1)

Broader conditions

Brain Diseases (3)  ·  Brain Diseases, Metabolic (3)  ·  Brain Diseases, Metabolic, Inborn (3)  ·  Central Nervous System Diseases (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Genetic Diseases, Inborn (3)  ·  Lipid Metabolism Disorders (3)  ·  Lipid Metabolism, Inborn Errors (3)  ·  Lipidoses (3)  ·  Lysosomal Storage Diseases, Nervous System (3)  ·  Metabolic Diseases (3)  ·  Metabolism, Inborn Errors (3)  ·  Nervous System Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Sphingolipidoses (3)

Interventions

Diet, Ketogenic (1)  ·  Genetic Engineering (1)  ·  Palliative Care (1)  ·  miglustat (1)

Sponsors

Tippi Mackenzie (1)  ·  University of Minnesota (1)  ·  University of Pittsburgh (1)

Countries

United States (2)

Top investigators

Jeanine R. Jarnes, PharmD (1)

Results publications

PMID 28476546

NIH funding

U54NS065768 (1)